Enter assignee name

EPO Patents = 6

Trademarks = 1

Forward Citations = 16

Loading Chart...

6 inventors (with patents filed for the assignee):

Isabel Aznarez (8 out of 12 patents)

Zhou Han (3 out of 3 patents)

Huw M Nash (2 out of 35 patents)

4. Adrian R Krainer (2 out of 14 patents)

5. Gene Liau (2 out of 2 patents)

6. Aditya Venkatesh (2 out of 2 patents)

7. Enxuan Jing (5 patents)

8. Baruch Ticho (0 patent)

9. Juergen Scharner (0 patent)

10. Jacob Kach (0 patent)

11. Adrian Krainer (0 patent)

12. Adrian Krainer (0 patent)

8 patents: Sort by Forward Citations

1. 12338437 - OPA1 antisense oligomers for treatment of conditions and diseases (2025-06-24),

2. 12060558 - Methods and compositions for treatment of cholesteryl ester storage disease (2024-08-13),

3. 11873490 - Antisense oligomers for treatment of conditions and diseases (2024-01-16),

4. 11814622 - OPA1 antisense oligomers for treatment of conditions and diseases (2023-11-14),

5. 11096956 - Antisense oligomers and uses thereof (2021-08-24),

6. 11083745 - Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome (2021-08-10),

7. 10913947 - Antisense oligomers for treatment of conditions and diseases (2021-02-09),

8. 10683503 - Antisense oligomers for treatment of conditions and diseases (2020-06-16),

Stoke Therapeutics is a biotechnology company focused on treating the underlying causes of severe genetic diseases by upregulating protein expression. Their innovative approach targets RNA to increase protein levels, offering potential new therapies for a range of disorders. Stoke Therapeutics is dedicated to improving the lives of patients and families affected by genetic diseases through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

8 Patents

#54 in Bedford, MA

#2,035 in Massachusetts

#34,944 in US

Bedford, MA, United States of America

Stoke Therapeutics, Inc.